Exhibition

Amicogen creates new values for sustainable growth for more than 16 years.

We have developed many innovative biocatalysts for pharmaceutical, food and feed industry by applying our proprietary i DNA Evolution™ Technology.

For the first time, we successfully developed CPC Acylase (CA) and 7-ACA synthesizing enzyme in the world.

We have established our local and global business based on the sincerity and trust in USA, Canada, China, Japan, and Europe. Our passion to better health world inspires us and creates new value for human health and nature. We will expand our business with our partners.

Biocatalysts is a global biotechnology company producing speciality enzymes at commercial scales for a variety of industries, such as food, flavour & fragrance, pharmaceutical, life sciences, fine chemicals and many more.

We offer both off-the-shelf enzyme products and a customised enzyme discovery, development and manufacturing service. The latter is where we excel, identifying an enzyme that exists as a concept on a database or mined from our metagenomics library, through to producing large scale commercial quantities of stable enzymes suitable for global shipment.

Biocatalysts has a wealth of enzyme knowledge and experience due to being in the business for over 30 years. This, along with our continuous investment in new technology and capabilities, enables us to exceed our customers’ enzyme expectations.

Biokal represents Resindion s.r.l./A subsidiary of Mitsubishi Chemical Corporation, Bio-Works Ltd. and Eurodia Industrie SA. We are offering solutions for preparative and industrial scale chromatography, purification processes and biocatalysis applications. Our products cover a range of ReliZyme™ enzyme carriers for immobilized enzyme applications, ReliSorb™ industrial chromatography media, Diaion™ resins, and WorkBeads™ agarose based chromatography media. Being located in the Netherlands we serve the Benelux countries and Germany with our products and services. Our services include product support as well as project development support.

BRAIN is one of Europe’s leading technology companies in the field of industrial biotechnology, the core discipline of Bioeconomy. BRAIN identifies previously untapped, efficient enzymes, microbial producer organisms or natural substances from complex biological systems that can be put to industrial use. BRAINs "BioScience" business executes collaboration business with industrial partners such as BASF, Ciba, Clariant, Evonik, DSM, Genencor, Henkel, Nutrinova, RWE, Sandoz, Schering, Südzucker or Symrise. "BioIndustrial" focuses on the development and commercialization of BRAIN’s own product lines. The approximately 220 employees of the BRAIN Group realized an operating performance of approximately 25.7 million Euros in the financial year 2014/2015.

Since November 2014 BRAIN owns a majority stake of WeissBiotech GmbH, which had been founded in 2002. Its unique proprietary know-how and network position in the specialty enzyme business allows WeissBioTech to occupy niche positions in the industrial enzyme field.

With its more than 100 products, WeissBioTech sold several thousand tons of enzyme products in more than 50 countries worldwide in 2013.

c-LEcta is a world-leading, technology-driven biotechnology company focusing on the transformation of bright scientific ideas into valuable industrial products. The company covers the value chain from early stage development down to commercial scale production and product approval. The company currently employs about 50 people and has established itself as leading technology company focused on the realization of high-value biotech products for applications in regulated markets like food & pharma, by its own or in close cooperation with the industry. c-LEcta delivers cost-efficient and sustainable production processes which enable to penetrate existing and to open new markets. The company started into business back in 2004 and since then has evolved into a premium partner for the industry. The company is working on a broad portfolio of product developments and could establish itself as a leading supplier to the industry, manufacturing unique, quality-controlled biotech products in large technical scale.

EnginZyme’s mission is to make biocatalysis the first choice for chemical process designers worldwide.
Biocatalysis offers a sustainable alternative to chemical catalysis in industry. Although the field of biocatalysis is now half a century old, biocatalysts are not yet the default choice for chemical process designers. EnginZyme was founded by a group of experienced Swedish scientists and entrepreneurs who believe that it is time for this to change. By creating products for easy and cost efficient implementation of biocatalytic processes, we help the chemical industry transition to a sustainable way of operating.

Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and single-use bioreactor vessels complement the range of highest-quality premium products. Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics, and at industrial laboratories performing process analysis, production, and quality assurance. Eppendorf was founded in Hamburg, Germany in 1945 and has more than 3,000 employees worldwide. The company has subsidiaries in 25 countries and is represented in all other markets by distributors.

GlycoSpot is a company dedicated to revolutionize high-throughput solutions for glycoscience. If you are looking for rapid screening of carbohydrate-modifying enzymes, GlycoSpot has the solution for you.

Hessen-Biotech is the central information, communication and cooperation platform for life science based activities in Hessen. The principle role of Hessen-Biotech is to link industry expertise in order to strengthen the innovation potential and competitiveness of companies and to promote the biotechnology industry in Hessen. It is administered and managed by the Hessen Trade & Invest GmbH in Wiesbaden.

Johnson Matthey Fine Chemicals supplies efficient and sustainable products and services for companies developing pharmaceuticals, agrochemicals and other fine and speciality chemicals. We are leading providers of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies. Customers trust us to provide them with expert complex chemistry solutions, optimising chemical processes and accelerating their innovation. We take pride in surpassing our customers' aims using a combination of deep R&D knowledge, large-scale global capabilities and a portfolio of unique technologies.

We offer a portfolio of high technology heterogeneous, homogeneous, chiral and bio catalysts which will enable your chemistry. Our global technical teams have market leading expertise and can find you the best solution with efficient and sustainable chemistry.

Our Catalyst offering provides our customers with an unmatched portfolio of catalysts and services including heterogeneous, homogeneous, chiral and bio catalysts to help make their chemistries more efficient, selective and sustainable while reducing cost, process steps and waste.

M+W Central Europe GmbH, a company of M+W Group, is a leading engineering and construction company for the life science industry. The portfolio includes individual as well as full-service solutions from concept studies and integrated 3D design up to the turnkey delivery of complex, sustainable production facilities and plants. Our clients benefit from our expertise in biotechnology shown in the last 20 years. M+W Central Europe realizes short project implementation times due to an extended basic design or modular facility concepts. 

Whether you require a new enzyme production facility, laboratory or optimization or extension of an existing facility, M+W Central Europe will find the best and most economical solutions to meet your deadlines.

Experienced project teams are your local professional partners for a turnkey construction, design & build (EPC) or EPCM realization. M+W Central Europe will realize your entire project based on current international guidelines, as for example EHEDG, EU GMP and FDA.

m2p-labs is a supplier of microbioreactors. The company focuses on microreaction and automated solutions for screening and bioprocess development. Commercialized products are the BioLector®, the BioLector® Pro, RoboLector® and the FlowerPlate® which provide an intelligent micro fermentation platform. This proprietary technology empowers the biotechnology, chemical and pharmaceutical industry to increase their number and the information content of microbial experiments (aerobic, microaerophilic and strict anaerobic). It enables the customers to conduct experiments with excellent efficiency and high quality at low costs. With the RoboLector® the company also enables automated fermentation of the whole bioprocess with its specific integration of the BioLector® tool into a liquid handling system.

NanoTemper Technologies is a globally operating, high-tech company providing solutions for biomolecular analytics. Our company develops, produces, and markets innovative technologies and instrumentation used by scientists across the globe to determine the affinity, conformation, and stability of biomolecules.

NanoTemper’s MicroScale Thermophoresis (MST) technology is a unique method to study biomolecular binding affinities in an easy, fast, and precise way.

The Surface Acoustic Wave (SAW) technology quantifies binding-induced conformational changes, as well as measure binding kinetics.

The nanoDSF, Prometheus instruments, offers a method for measuring ultra-high-resolution protein stability and aggregation by using intrinsic tryptophan and tyrosine fluorescence.

SpinChem provide technology solutions that reshape the way chemical process work is performed. Our goal is to surprise you with state of the art technology that changes your work to a simpler, quicker, more stable and less resource consuming process. For this we have developed the rotating bed reactor (RBR) technology to revolutionise mass transfer in heterogeneous reactions.

VBU is a catalyst for the transfer of research results into competitive products and services. VBU represents a cross-sectoral network, assisting its members in seeking and finding cooperation partners in all areas of the life sciences both on a national and an international scale.

VBU brings people together, at numerous events on hot topics and by the web-based Life Sciences database G2C - Gate to Cooperation. G2C provides a wealth of opportunities for communication and cooperation on a national and international scale. Additionally, VBU cooperates closely with other national and international organisations in the areas of biotechnology, pharmaceutical technology, diagnostics and also knowledge and technology transfer.

The Knowledge Company for Business and Science

Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners. Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley’s global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia.

Wiley-VCH, founded more than 90 years ago by German chemical societies and associations, produces English and German language books, journals, and data collection in the fields of chemistry, material science, physics, life sciences, business and trade.